CD274 and neoplasm: First, due to the time span of this NMA of more than 10 years, the expression of PD-L1 and tumor mutational burden were not reported in earlier studies (e.g., ECOG 4599, AVAiL, JO19907, and ERACLE trials), which might lead to a partially-biased conclusion.